Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 35
Filter
2.
Genet Mol Res ; 15(2)2016 May 23.
Article in English | MEDLINE | ID: mdl-27323076

ABSTRACT

The aim of this meta-analysis was to investigate the overall diagnostic and prognostic values of CTHRC1 expression in human cancer development. Based on the inclusion and exclusion criteria, 8 cohort studies were included in the meta-analysis. The data were extracted, and analyses were performed using a random-effects model. Summary odds ratios (ORs) and effect sizes (ESs) with 95% confidence intervals (CIs) were calculated to assess the strength of the associations. A total of 1065 cancer patients from the 8 studies were included in the meta-analysis. The results revealed a positive correlation of CTHRC1 protein expression in tumors with tumor-node-metastasis (TNM) stage and with lymph node (LN) metastasis (TNM: OR = 2.98, 95%CI = 1.48-6.00, P = 0.002; LN: OR = 4.26, 95%CI = 1.88-9.67, P = 0.001). CTHRC1 expression was higher in tumors with sizes ≥5 cm than in tumors with sizes <5 cm (OR = 2.39, 95%CI = 1.12-5.09, P = 0.024). Patients with higher CTHRC1 expression had decreased overall survival (OS) (ES = 1.78, 95%CI = 1.23-2.33, P < 0.001) and poorer disease-free survival (DFS) (ES = 1.71, 95%CI = 1.11-2.31, P < 0.001). Disease-stratified analyses yielded significantly different estimates of CTHRC1 levels in the majority of the subgroups (all P < 0.05). In conclusion, increased CTHRC1 expression is associated with advanced TNM stage, increased LN metastasis and tumor size, and decreased OS and DFS, indicating that CTHRC1 may be a biomarker for prognosis of cancer patients.


Subject(s)
Extracellular Matrix Proteins/biosynthesis , Neoplasms/genetics , Prognosis , Proteomics , Disease-Free Survival , Extracellular Matrix Proteins/genetics , Gene Expression Regulation, Neoplastic , Humans , Lymphatic Metastasis , Neoplasm Staging , Neoplasms/pathology
3.
Rio de Janeiro; s.n; s.n; 2016. 39 p. tab, ilus, graf.
Thesis in Portuguese | LILACS, BBO - Dentistry | ID: biblio-964020

ABSTRACT

Enterococcus faecalis é um patógeno oportunista com peculiar potencial para a manutenção da infecção perirradicular endodôntica após o preparo químico-mecânico do sistema de canais radiculares. Adicionalmente, possui aptidão para desenvolver-se em biofilme e apresenta em sua parede celular adesinas compatíveis com substratos colagênicos, como a composição da matriz extracelular da dentina e dos túbulos dentinários. Esse estudo propôs-se a caracterizar geneticamente 23 amostras de E faecalis isoladas de infecções endodônticas primárias através da técnica da reação em cadeia da polimerase (PCR, do inglês Polymerase Chain Reaction) e investigar a influência de COL I (colágeno tipo I), FN (fibronectina) e fibrinogênio (FBG) na formação de biofilme em superfície abiótica. Assim, após a sensibilização de ¾ dos poços de placas de poliestireno estéreis com 50 µl da solução de proteína de matriz (COL I, FN e FBG) na concentração de 1mg/ml, transferiu-se 50µl de suspensão bacteriana (1,5 x 108 bact/mL) correspondente a cada amostra, de modo a preencher tanto os poços sensibilizados como os não sensibilizados. A quantificação da formação de biofilme foi realizada por meio de leitura por densidade óptica, cujos resultados revelaram que houve formação de biofilme por todas as em superfície abiótica, porém com diferentes graus de intensidade. Todas as cepas foram identificadas geneticamente como Enterococcus faecalis e a presença do gene gelE foi dominante. Contudo, nenhuma apresentou amplificação para os genes esp e agg, e, apesar de 73,9% das amostras amplificarem para o gene ace, apenas 2 cepas (P7 e P75) isoladas de infecções endodônticas primárias tiveram aumento de formação de biofilme na presença de COL I (P<0,05). Embora a presença de FBG não forneça subsídio estatisticamente significante para a formação de biofilme, COL I e FN influenciaram na redução da formação do biofilme para a maior parte das amostras. É possível que a capacidade de formação de biofilme inerente ao E. faecalis e a afinidade para FN e COL I através da expressão gênica de ace contribuam substancialmente para a manutenção desse micro-organismo no ambiente radicular mesmo após o tratamento endodôntico minucioso.


Enterococcus faecalis is an opportunistic pathogen with peculiar potential to maintain the periradicular endodontic infection even after chemical-mechanical preparation of the root canal system. In addition, it has the ability to develop into biofilms and presents in your cell wall adhesins compatible with collagenous substrates, as the composition of the extracellular matrix of the dentine and dentinal tubules. This study aims to characterize genetically 23 samples of E. faecalis isolated from primary endodontic infections by Polymerase Chain Reaction (PCR) technique and investigate the influence of collagen type I (COL I), fibronectin (FN) and fibrinogen (FBG) in biofilm formation on abiotic surface. Thus, after the sensitization of ¾ the wells of sterile microtiter plates with 50 ul of matrix protein solution (COL I and FN FBG) at a concentration of 1mg / ml, was transferred 50mL of bacterial suspension (1.5 x 108 bact / ml) corresponding to each sample in order to fill both wells sensitized and non-sensitized. Quantification of biofilm formation was performed by optical density, so the results showed that there were biofilm formation by all strains on abiotic surface, but with different degrees of intensity. All strains were genetically identified as Enterococcus faecalis and the presence of gelE gene was prevalent. However, none showed amplification for the esp and agg gene, and, while 73.9% of the samples for amplifying ace gene, only 2 strains (P7 and P75) isolated from primary endodontic infections they had increased biofilm formation in the presence of COL I (P <0.05). Although the presence of FBG no provides significant support for the biofilm formation, COL I and FN were relevant influence in the reduction of biofilm formation for most of the samples. It is possible that the biofilm-forming ability inherent in E. faecalis and affinity for FN and COL I through ace gene expression contribute substantially to maintain of this microorganism in the root environment even after thorough endodontic treatment.


Subject(s)
Humans , Extracellular Matrix Proteins/biosynthesis , Extracellular Matrix Proteins/physiology , Gram-Positive Bacterial Infections , Enterococcus faecalis/genetics , Dental Pulp Cavity , Dentin , Genes, Bacterial , Periapical Periodontitis , Polymerase Chain Reaction , Biofilms , Root Canal Preparation
4.
BJU Int ; 113(5): 822-9, 2014 May.
Article in English | MEDLINE | ID: mdl-24053431

ABSTRACT

OBJECTIVES: To evaluate hyaluronan-mediated motility receptor (RHAMM) expression in normal, hyperplasic and neoplastic prostate tissue after various types and durations of androgen-deprivation therapy (ADT). Clinical and oncological data from men with localised prostate adenocarcinoma were also assessed and compared with RHAMM expression data. PATIENTS AND METHODS: Data from 367 men who underwent histological evaluation of the prostate were retrospectively evaluated under six conditions: (i) benign prostatic hyperplasia (BPH), (ii) BPH treated with finasteride, (iii) prostate cancer without ADT, (iv) prostate cancer treated with neoadjuvant ADT before prostatectomy (cyproterone 200 mg/day), (v) castration-resistant prostate cancer (CRPC), and (vi) normal peritumoral prostate tissue. Tissue microarrays were constructed and 1354 cores were evaluated for immunohistochemical RHAMM expression. RESULTS: There was no RHAMM expression in any tissue from normal patients or those with BPH or prostate cancer without ADT. There was RHAMM expression in 39.4% of prostate cancer tissues treated with ADT and in 46.2% of CRPC samples (P = 0.001). There was a significant increase in RHAMM expression with increased ADT duration in group 4, with a marked increase in RHAMM expression after 6-12 months of ADT (P = 0.04). No prognostic or clinical factors related to prostate cancer were associated with RHAMM expression. CONCLUSIONS: RHAMM expression in prostate cancer is directly associated with ADT. Significant RHAMM expression occurs as early as after 1 month of ADT and progressively increases with ADT duration. When prostate cancer becomes CRPC, RHAMM expression is higher. RHAMM expression was not associated with prostate cancer prognostic factors. RHAMM overexpression may contribute to the development of hormonal resistance in prostate cancer.


Subject(s)
Androgen Antagonists/therapeutic use , Extracellular Matrix Proteins/biosynthesis , Hyaluronan Receptors/biosynthesis , Precancerous Conditions/metabolism , Prostate/metabolism , Prostatic Hyperplasia/metabolism , Prostatic Neoplasms/metabolism , Aged , Disease Progression , Follow-Up Studies , Humans , Immunohistochemistry , Male , Middle Aged , Precancerous Conditions/pathology , Precancerous Conditions/therapy , Prognosis , Prostate/drug effects , Prostate/pathology , Prostatectomy , Prostatic Hyperplasia/pathology , Prostatic Hyperplasia/therapy , Prostatic Neoplasms/pathology , Prostatic Neoplasms/therapy , Retrospective Studies
5.
Neuroimmunomodulation ; 20(1): 29-38, 2013.
Article in English | MEDLINE | ID: mdl-23154307

ABSTRACT

OBJECTIVE: Our objective was to verify whether prenatal maternal periodontitis is a risk factor for the development of central nervous system disorders in rats. METHODS: Periodontitis was induced by placing a ligature around the upper and lower first molars in 9 female Wistar rats (experimental group); 9 rats were left unligated (control group). The maternal general activity in an open field was observed on gestational day (GD) 0, GD 4, and GD 14, and the maternal performance was assessed on the second day after birth. The pups' play behavior was assessed on postnatal day 30. The relative level of reelin was measured in the frontal cortex by real-time PCR analysis. RESULTS: The results showed that, compared with the control group, (1) the general activity in female rats with periodontitis was decreased, (2) the maternal performance of these rats was not modified by periodontitis, (3) the play behavior of pups from dams with periodontitis was decreased, and (4) there were no differences in the frontal cortex reelin levels of pups from dams with periodontitis. CONCLUSIONS: We conclude that pre- and postnatal periodontitis induces maternal sickness behavior and reduces the pups' play behavior without interference with frontal cortex reelin expression.


Subject(s)
Behavior, Animal/physiology , Maternal Behavior/physiology , Periodontal Diseases/complications , Pregnancy Complications , Social Behavior , Animals , Cell Adhesion Molecules, Neuronal/biosynthesis , Extracellular Matrix Proteins/biosynthesis , Female , Frontal Lobe/metabolism , Male , Nerve Tissue Proteins/biosynthesis , Pregnancy , Rats , Rats, Wistar , Real-Time Polymerase Chain Reaction , Reelin Protein , Serine Endopeptidases/biosynthesis
6.
Reprod Biol Endocrinol ; 10: 56, 2012 Aug 16.
Article in English | MEDLINE | ID: mdl-22897899

ABSTRACT

BACKGROUND: One of the unique characteristics of the female genital tract is the extensive tissue remodeling observed throughout the menstrual cycle. Multiple components of the extracellular matrix take part in this tissue rebuilding; however, the individual components involved have not been identified. METHODS: In the present study, the expression of extracellular matrix proteins and selected matrix metalloproteinase (MMP) activities in Fallopian tubes (FT) throughout the menstrual cycle were examined by PCR array, immunocytochemistry, zymography and bioinformatics. RESULTS: Of the eighty-four genes analyzed, eighty-three were expressed in the FT during at least one stage of the menstrual cycle. We observed a significant increase (>/=2-fold) in ADAMTS1, ADAMTS13, COL7A1, MMP3, MMP9, PECAM1, and THBS3 in the periovulatory phase compared to the follicular phase. Meanwhile, we observed a significant decrease (>/= 2-fold) in COL7A1, ICAM1, ITGA8, MMP16, MMP9, CLEC3B, SELE and TIMP2 in the lutheal phase compared to the periovulatory phase. Immunocytochemistry showed that MMP-3 and MMP-9 were localized in the endosalpinx during all phases of the menstrual cycle. Gelatin zymograms detected non-cycle-dependent protease activity. CONCLUSIONS: Several extracellular matrix components were regulated throughout the menstrual cycle in a cyclic pattern, suggesting a possible steroid regulation and a role in tissue remodeling and FT functions.


Subject(s)
Extracellular Matrix Proteins/biosynthesis , Fallopian Tubes/metabolism , Matrix Metalloproteinases/biosynthesis , Menstrual Cycle/metabolism , Transcriptome , Adult , Computational Biology , Female , Humans , Matrix Metalloproteinase 2/biosynthesis , Matrix Metalloproteinase 9/biosynthesis
7.
J Endod ; 38(7): 907-12, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22703652

ABSTRACT

INTRODUCTION: Mutations in the gene ALPL in hypophosphatasia (HPP) reduce the function of tissue nonspecific alkaline phosphatase, and the resulting increase in pyrophosphate (PP(i)) contributes to bone and tooth mineralization defects by inhibiting physiologic calcium-phosphate (P(i)) precipitation. Although periodontal phenotypes are well documented, pulp/dentin abnormalities have been suggested in the clinical literature although reports are variable and underlying mechanisms remains unclear. In vitro analyses were used to identify mechanisms involved in HPP-associated pulp/dentin phenotypes. METHODS: Primary pulp cells cultured from HPP subjects were established to assay alkaline phosphatase (ALP) activity, mineralization, and gene expression compared with cells from healthy controls. Exogenous P(i) was provided to the correct P(i)/PP(i) ratio in cell culture. RESULTS: HPP cells exhibited significantly reduced ALP activity (by 50%) and mineral nodule formation (by 60%) compared with the controls. The expression of PP(i) regulatory genes was altered in HPP pulp cells, including reduction in the progressive ankylosis gene (ANKH) and increased ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1). Odontoblast marker gene expression was disrupted in HPP cells, including reduced osteopontin (OPN), dentin matrix protein 1 (DMP1), dentin sialophosphoprotein (DSPP), and matrix extracellular phosphoprotein (MEPE). The addition of P(i) provided a corrective measure for mineralization and partially rescued the expression of some genes although cells retained altered messenger RNA levels for PP(i)-associated genes. CONCLUSIONS: These studies suggest that under HPP conditions pulp cells have the compromised ability to mineralize and feature a disrupted odontoblast profile, providing a first step toward understanding the molecular mechanisms for dentin phenotypes observed in HPP.


Subject(s)
Alkaline Phosphatase/genetics , Dental Pulp/physiopathology , Dentin/pathology , Diphosphates/metabolism , Hypophosphatasia/genetics , Odontoblasts/pathology , Tooth Calcification/genetics , Adolescent , Amino Acid Substitution , Analysis of Variance , Calcium/metabolism , Case-Control Studies , Dental Pulp/cytology , Diseases in Twins/genetics , Down-Regulation , Extracellular Matrix Proteins/biosynthesis , Extracellular Matrix Proteins/genetics , Female , Gene Expression , Glycoproteins/biosynthesis , Glycoproteins/genetics , Humans , Hypophosphatasia/pathology , Hypophosphatasia/physiopathology , Male , Mutation, Missense , Odontoblasts/metabolism , Osteopontin/biosynthesis , Osteopontin/genetics , Phosphate Transport Proteins/biosynthesis , Phosphate Transport Proteins/genetics , Phosphoproteins/biosynthesis , Phosphoproteins/genetics , Phosphoric Diester Hydrolases/biosynthesis , Phosphoric Diester Hydrolases/genetics , Primary Cell Culture , Pyrophosphatases/biosynthesis , Pyrophosphatases/genetics , Sialoglycoproteins/biosynthesis , Sialoglycoproteins/genetics , Statistics, Nonparametric , Young Adult
8.
J Periodontol ; 82(12): 1757-66, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21488756

ABSTRACT

BACKGROUND: The developing periodontium is sensitive to local levels of inorganic phosphate (P(i)) and inorganic pyrophosphate (PP(i)) as demonstrated by cementum phenotypes resulting from the loss of function of protein regulators of P(i)/PP(i) homeostasis. The progressive ankylosis protein (ANK) regulates the transport of PP(i), and progressive ankylosis gene (Ank) and knock-out (KO) mice feature a rapidly forming and thick cementum. We hypothesized that, besides affecting cementum formation, decreased extracellular PP(i) levels in Ank KO mice would also impact cementum regeneration. METHODS: Periodontal fenestration defects (approximately 2 mm in length, 1 mm in width, and 0.5 mm in depth) were created on buccal aspects of mandibular molars in Ank KO and wild-type (WT) mice. Mandibles were harvested at 15 and 30 days post-surgery for histology, histomorphometry, evaluation of in vivo fluorochrome labeling, and immunohistochemistry (IHC) for proteins including bone sialoprotein (BSP), osteopontin (OPN), dentin matrix protein 1 (DMP1), and ectonucleotide pyrophosphatase/phosphodiesterase 1 (NPP1). RESULTS: A greater amount of new cementum was observed in Ank KO mice at 15 and 30 days post-surgery (P <0.05), which was confirmed by fluorochrome labeling showing a higher new cementum appositional activity in defect areas in Ank KO mice versus controls. At days 15 and 30 during healing, regenerating cementum and associated cells in Ank KO samples recapitulated expression patterns mapped during development, including limited BSP and positive OPN and DMP1 in the cementum matrix as well as elevated NPP1 in cementoblasts. CONCLUSIONS: Within the limits of the study, these findings suggest that reduced local levels of PP(i) could promote increased cementum regeneration. Therefore, the local modulation of P(i)/PP(i) may be a potential therapeutic approach for achieving improved cementum regeneration.


Subject(s)
Dental Cementum/physiology , Diphosphates/metabolism , Phosphate Transport Proteins/physiology , Phosphates/metabolism , Regeneration/genetics , Animals , Extracellular Matrix Proteins/biosynthesis , Integrin-Binding Sialoprotein/biosynthesis , Mice , Mice, Knockout , Osteopontin/biosynthesis , Phosphoric Diester Hydrolases/biosynthesis , Pyrophosphatases/biosynthesis
9.
Reprod Biol Endocrinol ; 9: 22, 2011 Feb 04.
Article in English | MEDLINE | ID: mdl-21294898

ABSTRACT

BACKGROUND: We have previously demonstrated that four members of the family of small leucine-rich-proteoglycans (SLRPs) of the extracellular matrix (ECM), named decorin, biglycan, lumican and fibromodulin, are deeply remodeled in mouse uterine tissues along the estrous cycle and early pregnancy. It is known that the combined action of estrogen (E2) and progesterone (P4) orchestrates the estrous cycle and prepares the endometrium for pregnancy, modulating synthesis, deposition and degradation of various molecules. Indeed, we showed that versican, another proteoglycan of the ECM, is under hormonal control in the uterine tissues. METHODS: E2 and/or medroxiprogesterone acetate (MPA) were used to demonstrate, by real time PCR and immunoperoxidase staining, respectively, their effects on mRNA expression and protein deposition of these SLRPs, in the uterine tissues. RESULTS: Decorin and lumican were constitutively expressed and deposited in the ECM in the absence of the ovarian hormones, whereas deposition of biglycan and fibromodulin were abolished from the uterine ECM in the non-treated group. Interestingly, ovariectomy promoted an increase in decorin, lumican and fibromodulin mRNA levels, while biglycan mRNA conspicuously decreased. Hormone replacement with E2 and/or MPA differentially modulates their expression and deposition. CONCLUSIONS: The patterns of expression of these SLRPs in the uterine tissues were found to be hormone-dependent and uterine compartment-related. These results reinforce the existence of subpopulations of endometrial fibroblasts, localized into distinct functional uterine compartments, resembling the organization into basal and functional layers of the human endometrium.


Subject(s)
Biglycan/biosynthesis , Chondroitin Sulfate Proteoglycans/biosynthesis , Decorin/biosynthesis , Estradiol/pharmacology , Extracellular Matrix Proteins/biosynthesis , Keratan Sulfate/biosynthesis , Medroxyprogesterone Acetate/pharmacology , Proteoglycans/biosynthesis , Uterus/metabolism , Animals , Extracellular Matrix/metabolism , Female , Fibromodulin , Lumican , Mice , Uterus/drug effects
10.
J Dent Res ; 89(8): 791-6, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20395410

ABSTRACT

Studies on mechanisms underlying the differentiation of dental pulp stem cells are critical for the understanding of the biology of odontogenesis and for dental tissue engineering. Here, we tested the hypothesis that stem cells from exfoliated deciduous teeth (SHED) differentiate into functional odontoblasts and endothelial cells. SHED were seeded in tooth slice/scaffolds and implanted subcutaneously into immunodeficient mice. SHED differentiated into functional odontoblasts that generated tubular dentin, as determined by tetracycline staining and confocal microscopy. These cells also differentiated into vascular endothelial cells, as determined by beta-galactosidase staining of LacZ-tagged SHED. In vitro, vascular endothelial growth factor (VEGF) induced SHED to express VEGFR2, CD31, and VE-Cadherin (markers of endothelium) and to organize into capillary-like sprouts. VEGF induced ERK and AKT phosphorylation (indicative of differentiation), while inhibiting phosphorylation of STAT3 (indicative of 'stemness'). Collectively, this work demonstrates that SHED can differentiate into angiogenic endothelial cells and odontoblasts capable of generating tubular dentin.


Subject(s)
Adult Stem Cells/cytology , Dental Pulp/cytology , Dentin/metabolism , Endothelium, Vascular/cytology , Neovascularization, Physiologic/physiology , Odontoblasts/cytology , Animals , Cell Differentiation , Cells, Cultured , Endothelial Cells/cytology , Endothelial Cells/drug effects , Endothelium, Vascular/drug effects , Endothelium, Vascular/metabolism , Extracellular Matrix Proteins/biosynthesis , Extracellular Signal-Regulated MAP Kinases/metabolism , Humans , Mice , Mice, SCID , Odontoblasts/drug effects , Odontoblasts/metabolism , Phosphoproteins/biosynthesis , Phosphorylation , Proto-Oncogene Proteins c-akt/metabolism , Recombinant Proteins/pharmacology , STAT3 Transcription Factor/metabolism , Sialoglycoproteins/biosynthesis , Subcutaneous Tissue , Tissue Scaffolds , Tooth, Deciduous/cytology , Vascular Endothelial Growth Factor A/pharmacology , Vascular Endothelial Growth Factor Receptor-1/physiology
11.
J Endod ; 36(5): 826-31, 2010 May.
Article in English | MEDLINE | ID: mdl-20416427

ABSTRACT

INTRODUCTION: Stem cells are characterized by the ability to renew themselves through mitotic cell division and differentiating into a diverse range of specialized cell types. An important source of adult stem cells is the dental pulp. In dentistry, regenerative strategies are of importance because of hard dental tissue damage especially as result of caries lesions, trauma, or iatrogenic procedures. The regeneration of dental tissues relies on the ability of stem cells to produce extracellular (ECM) proteins encountered in the dental pulp tissue. Thus, the aim of this study was to analyze the expression and distribution of proteins encountered in dental pulp ECM (type I collagen, fibronectin, and tenascin) in stem cells. METHODS: Human immature dental pulp stem cells (hIDPSCs) from deciduous (DL-1 and DL-4 cell lines) and permanent (DL-2) teeth were used. The distribution of ECM proteins was observed using the immunofluorescence technique. The gene expression profile was evaluated using reverse transcription polymerase chain reaction (RT-PCR) analysis. RESULTS: Positive reactions for all ECM proteins were observed independently of the hIDPSCs analyzed. Type I collagen appeared less evident in DL-2 than in other hIDPSCs. Fibronectin and tenascin were less clear in DL-4. The RT-PCR reactions showed that type I collagen was lesser expressed in the DL-2 cells, whereas fibronectin and tenascin were similarly expressed in all hIDPSCs. CONCLUSIONS: The distribution and expression of ECM proteins differ among the hIDPSCs. These differences seemed to be related to the donor tooth conditions (deciduous or permanent, retained or erupted, and degree of root reabsorption).


Subject(s)
Dental Pulp/cytology , Extracellular Matrix Proteins/biosynthesis , Stem Cells/metabolism , Adolescent , Cell Line , Child , Child, Preschool , Collagen Type I/biosynthesis , Collagen Type I/genetics , Dentition, Permanent , Extracellular Matrix Proteins/genetics , Female , Fibronectins/biosynthesis , Fibronectins/genetics , Gene Expression Profiling , Humans , Male , Microscopy, Fluorescence , Reverse Transcriptase Polymerase Chain Reaction , Root Resorption , Stem Cells/cytology , Tenascin/biosynthesis , Tenascin/genetics , Tissue Donors , Tooth Eruption , Tooth, Deciduous
12.
Eur J Oral Sci ; 118(1): 19-28, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20156261

ABSTRACT

The aim of this study was to unravel the mechanisms by which interleukin (IL)-10, a potent pleiotropic cytokine, modulates alveolar bone homeostasis in C57BL/6 wild-type (WT) and IL-10 knockout (IL-10 KO) mice, evaluated at 8, 24, and 48 wk of age. Interleukin-10 KO mice presented significant alveolar bone loss when compared with WT mice, and this was not associated with changes in leukocyte counts or bacterial load. The levels of expression of messenger RNA (mRNA) for tumor necrosis factor-alpha (TNF-alpha), IL-1beta, IL-6, transforming growth factor-beta (TGF-beta), receptor activator of nuclear factor kappaB ligand (RANKL), osteoprotegerin (OPG), and matrix metalloproteinase 13 (MMP13) were similar between both strains, whereas a significant decrease of tissue inhibitor of metalloproteinase 1 (TIMP1) mRNA expression was found at 48 wk in IL-10 KO mice. The osteoblast markers core binding factor alpha1 (CBFA1) and type I collagen (COL-I) were expressed at similar levels in both strains, whereas the levels of alkaline phosphatase (ALP) and osteocalcin (OCN), and those of the osteocyte markers phosphate-regulating gene endopeptidases (PHEX) and dentin matrix protein 1 (DMP1) were significantly lower in IL-10 KO mice. Our results demonstrate that the alveolar bone loss in the absence of IL-10 was associated with a reduced expression of osteoblast and osteocyte markers, an effect independent of microbial, inflammatory or bone-resorptive pathways.


Subject(s)
Alveolar Bone Loss/metabolism , Interleukin-10/biosynthesis , Interleukin-10/physiology , Osteoblasts/metabolism , Osteocytes/metabolism , Alveolar Process/cytology , Alveolar Process/metabolism , Animals , Biomarkers/metabolism , Collagen Type I/biosynthesis , Densitometry , Down-Regulation , Extracellular Matrix Proteins/biosynthesis , Gene Expression , Interleukin-10/genetics , Leukocyte Count , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Osteocalcin/biosynthesis , PHEX Phosphate Regulating Neutral Endopeptidase/biosynthesis , Reverse Transcriptase Polymerase Chain Reaction , Tissue Inhibitor of Metalloproteinase-1/biosynthesis
13.
Eur Arch Otorhinolaryngol ; 267(2): 303-10, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19466441

ABSTRACT

This study evaluated the expression of fibronectin, tenascin and type I collagen in ameloblastomas and adenomatoid odontogenic tumors (AOTs) aiming to contribute with the comprehension of the differences in the biological behavior of these tumors. Immunohistochemical technique was performed in 20 cases of ameloblastoma (16 solid and 4 desmoplastic) and in 10 cases of AOT. All tumors presented moderate fibronectin expression in the stroma. Solid ameloblastomas showed intense expression of fibronectin at the epithelial-mesenchymal interface, whereas desmoplastic ameloblastomas revealed no immunoexpression of fibronectin at this site. Ameloblastomas presented stronger immunoreactivity to tenascin than AOTs, especially at the epithelial-mesenchymal interface. AOTs and desmoplastic ameloblastomas showed intense labeling for type I collagen. The patterns of expression of the proteins studied agree with the locally more invasive behavior of ameloblastomas in comparison to AOTs. Our results might suggest a less invasive behavior of desmoplastic ameloblastoma in comparison to solid ameloblastoma.


Subject(s)
Adenomatoid Tumor/metabolism , Ameloblastoma/metabolism , Collagen Type I/biosynthesis , Fibronectins/biosynthesis , Jaw Neoplasms/metabolism , Odontogenic Tumors/metabolism , Tenascin/biosynthesis , Adenomatoid Tumor/pathology , Ameloblastoma/pathology , Biomarkers, Tumor/biosynthesis , Extracellular Matrix Proteins/biosynthesis , Humans , Immunohistochemistry , Jaw Neoplasms/pathology , Odontogenic Tumors/pathology , Prognosis
14.
Quintessence Int ; 40(7): 553-8, 2009.
Article in English | MEDLINE | ID: mdl-19626229

ABSTRACT

OBJECTIVES: To analyze the expression of tenascin, fibronectin, collagens I and III, osteonectin, and bone morphogenetic protein 4 (BMP4) in the extracellular matrix of pulp tissue in primary teeth during physiologic root resorption. METHOD AND MATERIALS: Eighteen teeth were decalcified and equally distributed into 3 groups (group I, teeth with two-thirds root length; group II, teeth with one-third root length; and group III, teeth lacking the root). RESULTS: Immunohistochemical analysis showed that all the proteins were expressed. Tenascin, collagen I, and osteonectin showed strong and broad reactivity in group I, with weaker and rare reactivity in groups II and III. The expression of fibronectin, collagen III, and BMP4 did not vary with root resorption phase. CONCLUSION: The expression of tenascin, collagen I, and osteonectin was reduced in the extracellular matrix and odontoblasts during root resorption. This fact may be related to the decreasing pulp response to damage and treatment during the progression of root resorption.


Subject(s)
Dental Pulp/metabolism , Extracellular Matrix Proteins/biosynthesis , Root Resorption/metabolism , Tooth, Deciduous/metabolism , Collagen Type I/biosynthesis , Dental Pulp/cytology , Down-Regulation , Fibroblasts/metabolism , Humans , Immunohistochemistry , In Vitro Techniques , Odontoblasts/metabolism , Osteonectin/biosynthesis , Tenascin/biosynthesis , Tooth Exfoliation
15.
Braz Dent J ; 20(5): 365-9, 2009.
Article in English | MEDLINE | ID: mdl-20126903

ABSTRACT

Dentin matrix protein 1 (DMP1) is an acidic phosphoprotein that plays an important role in mineralized tissue formation by initiation of nucleation and modulation of mineral phase morphology. The purpose of the present study was to examine the immunoexpression of DMP1 in tooth germs of 7 human fetuses at different gestational ages (14, 16, 19, 20, 21, 23 and 24 weeks) comparing with completed tooth formation erupted teeth. The results showed the presence of DMP1 in the dental lamina, as well as in the cells of the external epithelium, stellate reticulum and stratum intermedium of the enamel organ. However, in the internal dental epithelium, cervical loop region and dental papilla some cells have not labeled for DMP1. In the crown stage, DMP1 was expressed in the ameloblast and odontoblast layer, as well as in the dentinal tubules of coronal dentin near the odontoblast area. Erupted teeth with complete tooth formation exhibited immunolabeling for DMP1 only in the dentinal tubules mainly close to the dental pulp. No staining was observed in the enamel, predentin or dental pulp matrix. DMP1 is present in all developing dental structures (dental lamina, enamel organ, dental papilla) presenting few immunoexpression variations, with no staining in mineralized enamel and dentin.


Subject(s)
Extracellular Matrix Proteins/biosynthesis , Phosphoproteins/biosynthesis , Tooth Germ/metabolism , Extracellular Matrix/metabolism , Extracellular Matrix Proteins/genetics , Fetal Development , Gene Expression , Humans , Immunohistochemistry , Odontoblasts/metabolism , Odontogenesis/physiology , Phosphoproteins/genetics
16.
Braz. dent. j ; Braz. dent. j;20(5): 365-369, 2009. ilus
Article in English | LILACS | ID: lil-537541

ABSTRACT

Dentin matrix protein 1 (DMP1) is an acidic phosphoprotein that plays an important role in mineralized tissue formation by initiation of nucleation and modulation of mineral phase morphology. The purpose of the present study was to examine the immunoexpression of DMP1 in tooth germs of 7 human fetuses at different gestational ages (14, 16, 19, 20, 21, 23 and 24 weeks) comparing with completed tooth formation erupted teeth. The results showed the presence of DMP1 in the dental lamina, as well as in the cells of the external epithelium, stellate reticulum and stratum intermedium of the enamel organ. However, in the internal dental epithelium, cervical loop region and dental papilla some cells have not labeled for DMP1. In the crown stage, DMP1 was expressed in the ameloblast and odontoblast layer, as well as in the dentinal tubules of coronal dentin near the odontoblast area. Erupted teeth with complete tooth formation exhibited immunolabeling for DMP1 only in the dentinal tubules mainly close to the dental pulp. No staining was observed in the enamel, predentin or dental pulp matrix. DMP1 is present in all developing dental structures (dental lamina, enamel organ, dental papilla) presenting few immunoexpression variations, with no staining in mineralized enamel and dentin.


A proteína da matriz dentinária 1 (DMP1) é uma fosfoproteína ácida que tem sido relacionada diretamente ao processo de mineralização dos tecidos em formação sendo iniciadora do processo de nucleação e modulação da fase mineral. O objetivo desse trabalho foi avaliar a imunoexpressão da DMP1 em germes dentários em diferentes fases da odontogênese, obtidos de 7 fetos humanos em diversos estágios gestacionais (14, 16, 19, 20, 21, 23 e 24 semanas), comparando-se com dentes com rizogênese completa. Os resultados mostraram que a DMP1 esteve expressa na lâmina dentária, bem como, nas células do epitélio externo, retículo estrelado e estrato intermediário do órgão do esmalte. Diferentemente, no epitélio interno do órgão do esmalte, alça cervical e papila dentária algumas células não apresentaram a DMP1. Nas fases de coroa, os ameloblastos e odontoblastos apresentaram marcação positiva para a DMP1, bem como os túbulos dentinários da dentina coronária próximos à região odontoblástica. Os dentes com rizogênese completa exibiram marcação para a DMP1 apenas nos túbulos dentinários principalmente próximos à polpa dentária. Nenhuma marcação foi observada na matriz de esmalte ou pré-dentina, nem na polpa dentária. Concluímos que a DMP1 está presente em todas as fases da odontogênese, tanto na lâmina dentária, órgão do esmalte, bem como na papila dentária, com pequenas variações de nuances de expressão, estando ausente na dentina e esmalte mineralizados.


Subject(s)
Humans , Extracellular Matrix Proteins/biosynthesis , Phosphoproteins/biosynthesis , Tooth Germ/metabolism , Extracellular Matrix Proteins/genetics , Extracellular Matrix/metabolism , Fetal Development , Gene Expression , Immunohistochemistry , Odontoblasts/metabolism , Odontogenesis/physiology , Phosphoproteins/genetics
17.
J Histochem Cytochem ; 56(11): 995-1001, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18645206

ABSTRACT

Fukutin-related protein (FKRP) is a protein involved in the glycosylation of cell surface molecules. Pathogenic mutations in the FKRP gene cause both the more severe congenital muscular dystrophy Type 1C and the milder Limb-Girdle Type 2I form (LGMD2I). Here we report muscle histological alterations and the analysis of 11 muscle proteins: dystrophin, four sarcoglycans, calpain 3, dysferlin, telethonin, collagen VI, alpha-DG, and alpha2-laminin, in muscle biopsies from 13 unrelated LGMD2I patients with 10 different FKRP mutations. In all, a typical dystrophic pattern was observed. In eight patients, a high frequency of rimmed vacuoles was also found. A variable degree of alpha2-laminin deficiency was detected in 12 patients through immunofluorescence analysis, and 10 patients presented alpha-DG deficiency on sarcolemmal membranes. Additionally, through Western blot analysis, deficiency of calpain 3 and dystrophin bands was found in four and two patients, respectively. All the remaining proteins showed a similar pattern to normal controls. These results suggest that, in our population of LGMD2I patients, different mutations in the FKRP gene are associated with several secondary muscle protein reductions, and the deficiencies of alpha2-laminin and alpha-DG on sections are prevalent, independently of mutation type or clinical severity.


Subject(s)
Muscle Proteins/biosynthesis , Muscular Dystrophies, Limb-Girdle/metabolism , Proteins/genetics , Adolescent , Adult , Blotting, Western , Child , Child, Preschool , Cytosol/metabolism , Extracellular Matrix Proteins/biosynthesis , Female , Fluorescent Antibody Technique , Humans , Male , Mutation , Pentosyltransferases , Sarcolemma/metabolism
18.
Article in English | MEDLINE | ID: mdl-18280971

ABSTRACT

Pulp capping is a treatment where a protective agent is applied to an exposed pulp to allow the maintenance of its vitality and function. The present study analyzed the immunohistochemical expression of fibronectin and type III collagen in human dental pulps submitted to direct pulp capping with calcium hydroxide [Ca(OH)2] or the Single Bond adhesive system (SBAS). The results demonstrated that both proteins were not expressed in the SBAS group, although in the group capped with Ca(OH)2 a diffuse labeling in the extracellular matrix was initially observed, followed by a late expression in the odontoblast-like layer and beneath the dentin bridge. It seems that application of adhesive systems in direct contact with healthy pulps will not lead to expression of proteins that are believed to be essential for pulpal repair. Moreover, Ca(OH)2 showed good biocompatibility properties with the dental pulp tissue, inducing the expression of reparative molecules, and therefore remains the material of choice for the treatment of accidental pulp exposures.


Subject(s)
Calcium Hydroxide/therapeutic use , Dental Pulp Capping/methods , Dental Pulp/metabolism , Dentin-Bonding Agents/therapeutic use , Extracellular Matrix Proteins/biosynthesis , Analysis of Variance , Bisphenol A-Glycidyl Methacrylate/therapeutic use , Collagen Type III/biosynthesis , Dentin, Secondary/metabolism , Fibronectins/biosynthesis , Humans , Immunohistochemistry , Resin Cements/therapeutic use
19.
J Cell Physiol ; 215(2): 410-21, 2008 May.
Article in English | MEDLINE | ID: mdl-18064627

ABSTRACT

Fibrotic disorders are typified by excessive connective tissue and extracellular matrix (ECM) deposition that precludes normal healing processes of different tissues. Connective tissue growth factor (CTGF) seems to be involved in the fibrotic response. Several muscular dystrophies are characterized by a progressive weakness and wasting of the musculature, and by extensive fibrosis. However, the exact role of CTGF in skeletal muscle is unknown. Here we show that myoblasts and myotubes are able to synthesize CTGF in response to transforming growth factor type-beta (TGF-beta) and lysophosphatidic acid (LPA). CTGF induced several ECM constituents such as fibronectin, collagen type I and alpha4, 5, 6, and beta1 integrin subunits in myoblasts and myotubes. CTGF had an important inhibitory effect on muscle differentiation evaluated by the decrease in the nuclear translocation of the early muscle regulatory factor myogenin and myosin. Remarkable, CTGF treatment of myoblasts induced their dedifferentiation, characterized by down regulating MyoD and desmin, two markers of committed myoblasts, together with a strong reorganization of cytoskeletal filaments. These results provide novel evidence for the underlying mechanisms and participation of skeletal muscle cells in the synthesis and role of CTGF inducing fibrosis, inhibiting myogenesis and dedifferentiating myoblasts.


Subject(s)
Cell Dedifferentiation , Immediate-Early Proteins/metabolism , Intercellular Signaling Peptides and Proteins/metabolism , Muscle, Skeletal/cytology , Muscle, Skeletal/metabolism , Animals , Biological Transport/drug effects , Cell Differentiation/drug effects , Cell Line , Cell Nucleus/metabolism , Connective Tissue Growth Factor , Cytoskeleton/drug effects , Desmin/metabolism , Down-Regulation , Extracellular Matrix Proteins/biosynthesis , Immediate-Early Proteins/biosynthesis , Immediate-Early Proteins/pharmacology , Intercellular Signaling Peptides and Proteins/biosynthesis , Intercellular Signaling Peptides and Proteins/pharmacology , Lysophospholipids/pharmacology , Mice , Muscle Fibers, Skeletal/drug effects , Muscle Fibers, Skeletal/metabolism , Muscle, Skeletal/drug effects , MyoD Protein/metabolism , Myoblasts/cytology , Myoblasts/drug effects , Myoblasts/metabolism , Myogenin/metabolism , Myosins/metabolism , Recombinant Proteins/pharmacology , Transforming Growth Factor beta/pharmacology
20.
J Neurochem ; 101(1): 27-40, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17241119

ABSTRACT

In contrast to mammals, salamanders have a remarkable ability to regenerate their spinal cord and recover full movement and function after tail amputation. To identify genes that may be associated with this greater regenerative ability, we designed an oligonucleotide microarray and profiled early gene expression during natural spinal cord regeneration in Ambystoma mexicanum. We sampled tissue at five early time points after tail amputation and identified genes that registered significant changes in mRNA abundance during the first 7 days of regeneration. A list of 1036 statistically significant genes was identified. Additional statistical and fold change criteria were applied to identify a smaller list of 360 genes that were used to describe predominant expression patterns and gene functions. Our results show that a diverse injury response is activated in concert with extracellular matrix remodeling mechanisms during the early acute phase of natural spinal cord regeneration. We also report gene expression similarities and differences between our study and studies that have profiled gene expression after spinal cord injury in rat. Our study illustrates the utility of a salamander model for identifying genes and gene functions that may enhance regenerative ability in mammals.


Subject(s)
Ambystoma/genetics , Gene Expression Regulation/genetics , Nerve Regeneration/genetics , Neuronal Plasticity/genetics , Spinal Cord Injuries/genetics , Spinal Cord/physiology , Ambystoma/anatomy & histology , Animals , Down-Regulation/genetics , Extracellular Matrix Proteins/biosynthesis , Extracellular Matrix Proteins/genetics , Gene Expression Profiling , Nerve Tissue Proteins/biosynthesis , Nerve Tissue Proteins/genetics , Neurons/cytology , Neurons/physiology , Oligonucleotide Array Sequence Analysis , RNA, Messenger/analysis , RNA, Messenger/metabolism , Rats , Species Specificity , Spinal Cord/cytology , Stem Cells/cytology , Stem Cells/physiology , Up-Regulation/genetics
SELECTION OF CITATIONS
SEARCH DETAIL